Intervention for Persons Leaving Residential Substance Abuse Treatment

October 31, 2022 updated by: New York University

Intervention for Persons With Co-Occurring Disorders Leaving Residential Tx

This research uses a multi-phase approach to adapt and implement an established intervention, Critical Time Intervention, for a new population and setting among individuals with substance use who are at risk of relapse following residential substance abuse treatment. The goals of the study are to: (PHASE 1) identify challenges and strategies of community reentry among individuals in residential substance abuse treatment and their providers and social support networks (e.g., family, friends, community members); (PHASE 2) adapt CTI for individuals in residential substance abuse treatment to prepare them for discharge and transition back into the community; and (PHASE 3) conduct a pilot study to examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services.

Study Overview

Detailed Description

This randomized pilot study will examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services. More specifically, 60 participants will be randomized to either CTI (n=30) or enhanced usual discharge planning services (n=30) at the time of discharge. Participants will complete a baseline interview (prior to randomization) and 3-, 6-, 9- and 12-month follow-up assessments post-discharge.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10003
        • New York University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Eligible participants will be enrolled in residential substance abuse treatment and who are at least 18 years of age, speak English, and expect to be discharged within 3 months.

Exclusion Criteria:

  • Individuals that do not meet the aforementioned inclusion criteria will be excluded from the study.More specifically, the following categories will be excluded:

    1. Anyone under the age of 18
    2. Non-English speaking individuals due to limited resources
    3. Individuals who are considered vulnerable/protected populations, including children, pregnant women, and prisoners.
    4. Individuals judged by clinical treatment staff to be in immediate crisis, i.e., suicide watch or inadequate decisional capacity to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Critical Time Intervention-Residential
CTI-R is a 9-month, assertive outreach and linkage program.
CTI-R is a 9-month, time-limited intervention that aims to produce an enduring impact by effectively linking individuals to both professional services (substance abuse and health and mental health providers) and social supports (e.g., family and friends) and by providing emotional and practical support. Participants in the CTI-R condition will also receive usual discharge services from the residential substance abuse treatment program.
The enhanced usual discharge condition encompasses the regular discharge services offered at the residential treatment program plus enhanced transition services.
Active Comparator: Enhanced Usual Discharge-Residential
The enhanced usual discharge condition includes usual discharge services plus enhanced transition services.
The enhanced usual discharge condition encompasses the regular discharge services offered at the residential treatment program plus enhanced transition services.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Enrollment
Time Frame: Baseline
Proportion of participants enrolled in the study as measured by the research records
Baseline
Change in retention
Time Frame: 3, 6, 9, and 12 months
Proportion of participants completed the study as measured by the research records
3, 6, 9, and 12 months
Short-term Relapse
Time Frame: 3 months
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
3 months
Use of aftercare services
Time Frame: 3 months
Proportion of participants who were linked to aftercare services (i.e. substance use treatment) at the time of discharge as measured by the Treatment Service Review (TSR)
3 months
Housing
Time Frame: 3 months
Proportion of participants housed at the time of discharge
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short-term Social Support
Time Frame: 3 months
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
3 months
Short-term Self-Efficacy
Time Frame: 3 months
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
3 months
Short-term Mental Health
Time Frame: 3 months
Level of mental health severity as measured by the Brief Symptom Inventory
3 months
Change in Relapse
Time Frame: 3, 6, and 9 months
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
3, 6, and 9 months
Long-term Relapse
Time Frame: 12 months
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
12 months
Change in Social Support
Time Frame: 3, 6, and 9 months
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
3, 6, and 9 months
Long-term Social Support
Time Frame: 12 months
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
12 months
Change in Self-Efficacy
Time Frame: 3, 6, and 9 months
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
3, 6, and 9 months
Long-term Self-Efficacy
Time Frame: 12 months
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
12 months
Change in Mental Health
Time Frame: 3, 6, and 9 months
Level of mental health severity as measured by the Brief Symptom Inventory
3, 6, and 9 months
Long-term Mental Health
Time Frame: 12 months
Level of mental health severity as measured by the Brief Symptom Inventory
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer I Manuel, PhD, New York University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

May 1, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

January 25, 2016

First Submitted That Met QC Criteria

February 1, 2016

First Posted (Estimate)

February 2, 2016

Study Record Updates

Last Update Posted (Actual)

November 1, 2022

Last Update Submitted That Met QC Criteria

October 31, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • K01DA035330 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use Disorders

Clinical Trials on Critical Time Intervention-Residential (CTI-R)

Subscribe